# NEWLEOS THERAPEUTICS, INC.: NTX-2001, a trace amine-associated receptor 1 (TAAR1) partial agonist, for the treatment of Cocaine Use Disorder

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | NEWLEOS THERAPEUTICS, INC. |
| Location | HOPKINTON, MA |
| Project | NTX-2001, a trace amine-associated receptor 1 (TAAR1) partial agonist, for the treatment of Cocaine Use Disorder |
| Project number | 1UG3DA066264-01 |
| Mechanism | UG3 |
| Institute | National Institute on Drug Abuse |
| Award | $3,097,247 |
| Awarded | 2026-09-08 |
| Project period | 2026-09-15 to 2027-08-31 |
| UEI | SMHBT7JZMK31 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11390841). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.